TRCare Brings Absolute Joy to Stroke Patients
October 12, 2018 by Morgan Xin
TRCare is a company that provides stroke patients with tele rehabilitation care. Their product utilizes AI and VR technology to help stroke patients recover to their highest level possible.
On October 11th, I visited their office at Palo Alto and interviewed three co-founders: Kit Sun, Jim Fenstermaker, and Li Lan.
TRCare the name stands for Tele Rehabilitation care. The product itself is called Occupational Therapy System, OTS. They were working with UC Irvine since about 2012, and then launched TRCare in 2017 to commercialize the scientific innovation.
They will have a finalized product by the end of this year, and they are looking for some big clinical trials in the U.S. and China.
On October 11th, I visited their office at Palo Alto and interviewed three co-founders: Kit Sun, Jim Fenstermaker, and Li Lan.
TRCare the name stands for Tele Rehabilitation care. The product itself is called Occupational Therapy System, OTS. They were working with UC Irvine since about 2012, and then launched TRCare in 2017 to commercialize the scientific innovation.
They will have a finalized product by the end of this year, and they are looking for some big clinical trials in the U.S. and China.
Co-Founder Kit Sun Co-Founder Jim Fenstermaker TRCare's portable product
During the interview, Kit Sun demonstrated their transformative, and entertaining system.
Jim Fenstermaker introduced the reason they initiated the project and their vision to bring more happiness to stroke patients.
He said:"we're finding so many more applications with this product, potentially not just stroke, but with traumatic brain injury. And there's several other areas that we're looking at running some clinical trials and as well. So the thing that I think motivates me or us to keep going is there's so many people that we can help in so many different areas that have been affected by lots of different trauma. "
When they started working with UC Irvine, it had already gone through a 12 person clinical trial, and they were also in the middle of 124 person clinical trial that lasted two years, and just finished this past April 2018.
Mr Fenstermaker told me that the results of the first trial were very promising, which spurred the second trial. And the results of the second trial were announced in Sweden in this past May of 2018, and the results were very positive. The trial itself was to determine if using the console and system was equal to getting in person therapy from a therapist. And the results showed that it was at least as equal to.
TRCare's current system focuses on upper body at the moment. but they are now focusing on the research of lower body and specifically foot and lower leg.
They are still discovering new ideas and ways to apply what they have so far. They are also discovering new methodologies and new technologies that could either become a partnership with what they are doing or become part of the system itself.
TRCare has been talking with one of the largest rehab hospitals in China, and they seem very receptive to starting a trial with TRCare probably sometime in 2019, first of second quarter.
Here in the US, TRCare are looking to talk to several hospitals to start using the system before getting the FDA approval.
Mr Fenstermaker has great confidence in the product: "Every day that goes by, we're finding more and more clinicians and hospitals that have ideas for us to use our system and to run new clinical trials for more modalities and just stroke."
He encouraged investors that the potential for this product is unlimited, "I think that the longer they wait, the harder it's going to be get for them to become part of our company."
Jim Fenstermaker introduced the reason they initiated the project and their vision to bring more happiness to stroke patients.
He said:"we're finding so many more applications with this product, potentially not just stroke, but with traumatic brain injury. And there's several other areas that we're looking at running some clinical trials and as well. So the thing that I think motivates me or us to keep going is there's so many people that we can help in so many different areas that have been affected by lots of different trauma. "
When they started working with UC Irvine, it had already gone through a 12 person clinical trial, and they were also in the middle of 124 person clinical trial that lasted two years, and just finished this past April 2018.
Mr Fenstermaker told me that the results of the first trial were very promising, which spurred the second trial. And the results of the second trial were announced in Sweden in this past May of 2018, and the results were very positive. The trial itself was to determine if using the console and system was equal to getting in person therapy from a therapist. And the results showed that it was at least as equal to.
TRCare's current system focuses on upper body at the moment. but they are now focusing on the research of lower body and specifically foot and lower leg.
They are still discovering new ideas and ways to apply what they have so far. They are also discovering new methodologies and new technologies that could either become a partnership with what they are doing or become part of the system itself.
TRCare has been talking with one of the largest rehab hospitals in China, and they seem very receptive to starting a trial with TRCare probably sometime in 2019, first of second quarter.
Here in the US, TRCare are looking to talk to several hospitals to start using the system before getting the FDA approval.
Mr Fenstermaker has great confidence in the product: "Every day that goes by, we're finding more and more clinicians and hospitals that have ideas for us to use our system and to run new clinical trials for more modalities and just stroke."
He encouraged investors that the potential for this product is unlimited, "I think that the longer they wait, the harder it's going to be get for them to become part of our company."